Sputum protein profiles for monitoring lung pathophysiology in chronic lung diseases

J. Huang, A. Atrih, A. Barton, C. Palmer, G. Devereus (Dundee, Aberdeen, United Kingdom)

Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Session: Recent progress in mechanisms and diagnostics of COPD and asthma
Session type: Poster Discussion
Number: 1763
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Huang, A. Atrih, A. Barton, C. Palmer, G. Devereus (Dundee, Aberdeen, United Kingdom). Sputum protein profiles for monitoring lung pathophysiology in chronic lung diseases. Eur Respir J 2012; 40: Suppl. 56, 1763

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Quantitative assessment of lung pathology in interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 243s
Year: 2001

Role of BALF in differential diagnosis of smoking related interstitial lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006

Cytokine profiles in the lungs of patients with interstitial and obstructive lung diseases
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018

Phenotypic analysis of BAL lympocytes and respiratory function in chronic inflammatory lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 543s
Year: 2005

BAL protein profiles specific of different interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012

The relation between pathogenic bacteriology in sputum and lung function in patients with acute exacerbation of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002

Senotherapies for chronic lung disease
Source: ERS Lung Science Conference 2020
Year: 2020


The characteristics of mycobacterioses in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2016
Year: 2016

Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017

Sputum cytokine profiling according to the type of airway inflammation in obstructive pulmonary diseases
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018

Peroxidation processes, cytokines, BALF and blood cytology in patients with occupational lung diseases and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 275s
Year: 2002

The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 674s
Year: 2006

Surfactant therapy for acute lung injury and other lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 210s
Year: 2003

Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005


Exhaled volatile organic compounds as biomarkers for respiratory diseases
Source: Eur Respir Monogr 2010; 49: 130-139
Year: 2010